ST
CELG

Smithfield Trust’s Celgene Corp CELG Stock Holding History

Smithfield Trust’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-149
Closed -$15K – 1031
2019
Q3 		$15K Sell
149
-1,089
-88% -$103K ﹤0.01% 689
2019
Q2 		$115K Hold
1,238
– – 0.01% 376
2019
Q1 		$117K Buy
1,238
+656
+113% +$57.4K 0.01% 350
2018
Q4 		$37K Sell
582
-1,706
-75% -$126K ﹤0.01% 513
2018
Q3 		$205K Sell
2,288
-22
-1% -$1.94K 0.02% 281
2018
Q2 		$184K Buy
2,310
+398
+21% +$33K 0.02% 298
2018
Q1 		$170K Buy
1,912
+441
+30% +$42.3K 0.02% 306
2017
Q4 		$154K Buy
1,471
+187
+15% +$21.1K 0.02% 333
2017
Q3 		$187K Buy
1,284
+55
+4% +$7.49K 0.03% 285
2017
Q2 		$160K Buy
1,229
+323
+36% +$39.6K 0.02% 330
2017
Q1 		$113K Sell
906
-249
-22% -$29.8K 0.02% 385
2016
Q4 		$134K Sell
1,155
-155
-12% -$17.3K 0.02% 356
2016
Q3 		$137K Buy
1,310
+28
+2% +$3.03K 0.02% 343
2016
Q2 		$127K Buy
1,282
+142
+12% +$14.7K 0.02% 346
2016
Q1 		$114K Hold
1,140
– – 0.02% 362
2015
Q4 		$136K Sell
1,140
-2,479
-68% -$287K 0.03% 331
2015
Q3 		$392K Sell
3,619
-101
-3% -$12.5K 0.08% 159
2015
Q2 		$430K Sell
3,720
-109
-3% -$12.5K 0.08% 161
2015
Q1 		$441K Sell
3,829
-142
-4% -$17K 0.09% 171
2014
Q4 		$444K Sell
3,971
-249
-6% -$26.3K 0.09% 166
2014
Q3 		$400K Buy
4,220
+2,866
+212% +$259K 0.08% 191
2014
Q2 		$117K Sell
1,354
-1,374
-50% -$104K 0.02% 420
2014
Q1 		$191K Buy
2,728
+88
+3% +$6.97K 0.04% 351
2013
Q4 		$223K Buy
2,640
+86
+3% +$6.8K 0.05% 309
2013
Q3 		$197K Sell
2,554
-496
-16% -$34.8K 0.05% 324
2013
Q2 		$178K Buy
+3,050
New +$184K 0.04% 329

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Smithfield Trust's CELG Position: Q4 2019 in Review

Smithfield Trust sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 149 shares — an estimated $15K sold.

Smithfield Trust first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $444K in Q4 2014. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Smithfield Trust reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Smithfield Trust sold 149 Celgene Corp shares in Q4 2019, an estimated $15K.
  • Smithfield Trust first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Smithfield Trust's Celgene Corp position peaked at $444K in Q4 2014.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Smithfield Trust's 13F filing for Q4 2019, filed 13 Feb 2020.